Nectar Lifesciences Board to consider final dividend

06 May 2013 Evaluate

Nectar Lifesciences has informed that a meeting of the Board of Directors of the Company will be held on May 15, 2013, to consider and approve the following: The Audited Financial Results for Financial Year 2012-13, Balance Sheet of the Company as at March 31, 2013 and Profit A Loss Accounts for the financial year ended on March 31, 2013 and matters related thereto, and recommendation of final dividend to the Members of the Company for Financial Year 2012-13.

The above information is a part of company’s filings submitted to BSE.

Nectar Lifesciences Share Price

24.51 -1.28 (-4.96%)
04-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1709.40
Dr. Reddys Lab 1109.75
Cipla 1415.55
Lupin 1971.10
Zydus Lifesciences 866.65
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...